Month: March 2020

Zhonghuan (002129)： Photovoltaic production continues to expand and semiconductor business grows rapidly

Zhonghuan (002129): Photovoltaic production continues to expand and semiconductor business grows rapidly Event: The company released its 2018 annual report and achieved a total operating income of 137 in 2018. 56 trillion, a simultaneous increase of 42. 63%; net operating cash flow was 170,770. 910,000 yuan, an increase of 62 in ten years. 37%; net … Read moreZhonghuan (002129)： Photovoltaic production continues to expand and semiconductor business grows rapidly

Xugong Machinery (000425)： The first quarter notice doubles, the follow-up catalyst continues

Xugong Machinery (000425): The first quarter notice doubles, the follow-up catalyst continues Event: On April 14, 2019, the company released its annual performance report, and its operating income in 2018 was 444. 100,000 yuan, an increase of 52 in ten years. 45%, net profit attributable to mother 20. 4.2 billion, an annual increase of 100. … Read moreXugong Machinery (000425)： The first quarter notice doubles, the follow-up catalyst continues

WuXi PharmaTech (603259) 2019Q3 Review： Attacking giants continue to grow faster than expected

WuXi PharmaTech (603259) 2019Q3 Review: Attacking giants continue to grow faster than expected Event: The company released the third quarter report of 2019, and the company achieved operating income of 92 in the first three quarters of 2019.79 trillion, an increase of 34 in ten years.06%; net profit attributable to mother 17.65 ppm, a reduction … Read moreWuXi PharmaTech (603259) 2019Q3 Review： Attacking giants continue to grow faster than expected

Huaxin Cement (600801) 2018 Annual Report Comments： Q4 Profits, New High Aggregate Environmental Protection Is Expected to Be a New Bright Spot

Huaxin Cement (600801) 2018 Annual Report Comments: Q4 Profits, New High Aggregate Environmental Protection Is Expected to Be a New Bright Spot This report reads: The company announced its 18-year annual report. The fourth quarter profit hits a record high. In the future, aggregate environmental protection is expected to become a new bright spot for … Read moreHuaxin Cement (600801) 2018 Annual Report Comments： Q4 Profits, New High Aggregate Environmental Protection Is Expected to Be a New Bright Spot

East China Pharmaceutical (000963) semi-annual report comment： 2019H1 performance basically in line with expectations

East China Pharmaceutical (000963) semi-annual report comment: 2019H1 performance basically in line with expectations Key points of investment: The company announced the semi-annual report for 2019 and realized revenue of 182. 4.9 billion, an annual increase of 19. 08%; net profit attributable to mother 15. 9.6 billion, an annual increase of 23. 42%; net profit … Read moreEast China Pharmaceutical (000963) semi-annual report comment： 2019H1 performance basically in line with expectations

China CITIC Bank (601998)： Retail Transformation Continues to Advance Asset Quality Pressures

China CITIC Bank (601998): Retail Transformation Continues to Advance Asset Quality Pressures Event: Recently, CITIC Bank released the first half of 2019 results, and the company reported that it actually achieved operating income of 931. 50 ppm, an increase of 14 in ten years. 93%; net profit attributable to shareholders of the parent company was … Read moreChina CITIC Bank (601998)： Retail Transformation Continues to Advance Asset Quality Pressures

Yanjinpuzi (002847) performance preview comment： cut into large categories + market nationalization performance continued high growth can be expected

Yanjinpuzi (002847) performance preview comment: cut into large categories + market nationalization performance continued high growth can be expected Event: The company releases 2019 performance forecast: It is estimated 杭州龙凤夜网 that the net profit attributable to shareholders of listed companies in 2019 will be 120-130 million yuan, an annual increase of 70.18% -84.36%.Exceed previous performance … Read moreYanjinpuzi (002847) performance preview comment： cut into large categories + market nationalization performance continued high growth can be expected

Yunnan Baiyao (000538)： Pre-received income affects the growth rate distribution of the pharmaceutical and health divisions in the first quarter

Yunnan Baiyao (000538): Pre-received income affects the growth rate distribution of the pharmaceutical and health divisions in the first quarter Event: Yunnan Baiyao released the 2019 quarterly report. Steady growth in performance. Yunnan Baiyao’s quarterly revenue increased by 10% annually, net profit increased by 5%, and non-net profit increased by 8%. 5%, EPS 0. 81 … Read moreYunnan Baiyao (000538)： Pre-received income affects the growth rate distribution of the pharmaceutical and health divisions in the first quarter

Hualan Biological (002007) Interim Review： Bloodline business confirmed to get out of trough flu vaccine business

Hualan Biological (002007) Interim Review: Bloodline business confirmed to get out of trough flu vaccine business Matters: The company released its semi-annual report for 2019, which effectively achieved revenue14. 3.0 billion (+16. 77%); net profit attributable to shareholders of listed companies5. 07 billion (+11. 94%); basic profit income 0. 36 yuan. Comment: The blood business … Read moreHualan Biological (002007) Interim Review： Bloodline business confirmed to get out of trough flu vaccine business

China International Travel Service (601888)： Interim Report Results Meet Expected Strong Endogenous Growth

China International Travel Service (601888): Interim Report Results Meet Expected Strong Endogenous Growth Predicted 71% growth in earnings growth The company released a 1H19 performance report, with an estimated revenue of 243. 44 ppm, an increase of 15 in ten years. 5%; net profit attributable to mother 32. 79 trillion, an increase of 70 in … Read moreChina International Travel Service (601888)： Interim Report Results Meet Expected Strong Endogenous Growth